Accelerated ageing: from mechanism to therapy through animal models

Area of Science:

• Gerontology
• Molecular Biology
• Genetics

Background:

• Accelerated ageing syndromes like Hutchinson-Gilford progeria syndrome (HGPS) offer insights into ageing.
• HGPS is often caused by LMNA mutations, producing progerin, a farnesylated protein.
• Accumulation of farnesylated prelamin A causes nuclear envelope issues and a progeroid phenotype.

Purpose of the Study:

• To investigate the molecular mechanisms of HGPS using Face-1/Zmpste24-deficient mice.
• To explore therapeutic strategies targeting protein prenylation for HGPS treatment.

Main Methods:

• Utilized Face-1/Zmpste24-deficient mice to model HGPS.
• Investigated the effects of inhibiting protein farnesylation and geranylgeranylation.
• Tested a combination therapy of statins and aminobisphosphonates.

Main Results:

• Farnesylated prelamin A accumulation causes severe nuclear abnormalities and a progeroid phenotype.
• Inhibiting prenylation reversed ageing symptoms and extended lifespan in mouse models.
• Combined statin and aminobisphosphonate treatment inhibited both farnesylation and geranylgeranylation of prelamin A and progerin.

Conclusions:

• Targeting both farnesylation and geranylgeranylation is crucial for HGPS treatment.
• A combination of statins and aminobisphosphonates shows therapeutic potential for progeroid syndromes.
• Animal models are vital for understanding ageing mechanisms and testing treatments.